HCAT
Health Catalyst, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$1.71
−0.87%1
Insider buys (3m)
0
Insider sells (3m)
$105.4K
Net value (3m)
-21.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 5, 2026 | Reller Tami · director | A-Award | 128,851 | $0.00 |
| Sep 16, 2026 | Kohl Simeon · director, officer: Chief Executive Officer | Purchase | 59,000 | $1.79 |
| Sep 16, 2026 | Kohl Simeon · director, officer: Chief Executive Officer | A-Award | 2,747,385 | $0.00 |
| Sep 11, 2026 | Albert Benjamin · director, officer: CEO | F-InKind | 35,244 | $1.67 |
| Sep 3, 2026 | Alger Jason · officer: Chief Financial Officer | F-InKind | 17,973 | $1.70 |
| Sep 3, 2026 | Landry Benjamin · officer: General Counsel | F-InKind | 13,167 | $1.70 |
| Sep 3, 2026 | Larson-Green Julie · director | A-Award | 9,766 | $0.00 |
| Sep 3, 2026 | Albert Benjamin · director, officer: CEO | F-InKind | 321 | $1.70 |
| Jul 20, 2026 | Hoggard Green Jill · director | A-Award | 80,691 | $0.00 |
| Jul 20, 2026 | Spencer Justin · director | A-Award | 80,691 | $0.00 |
| Jul 20, 2026 | Nelson Steven H · director | A-Award | 80,691 | $0.00 |
| Jul 20, 2026 | Larson-Green Julie · director | A-Award | 80,691 | $0.00 |
| Jun 15, 2026 | Albert Benjamin · director, officer: CEO | F-InKind | 34,485 | $1.69 |
| Jun 3, 2026 | Larson-Green Julie · director | A-Award | 12,710 | $0.00 |
| Jun 3, 2026 | Landry Benjamin · officer: General Counsel | F-InKind | 13,779 | $1.37 |
| Jun 3, 2026 | Alger Jason · officer: Chief Financial Officer | F-InKind | 18,804 | $1.37 |
| Jun 3, 2026 | Albert Benjamin · director, officer: CEO | F-InKind | 336 | $1.37 |
| Jun 3, 2026 | Llewelyn Linda · officer: Chief People Officer | F-InKind | 8,519 | $1.37 |
| May 4, 2026 | Nelson Steven H · director | A-Award | 154,808 | $0.00 |
| May 1, 2026 | Albert Benjamin · director, officer: CEO | A-Award | 1,124 | $0.00 |
| May 1, 2026 | Albert Benjamin · director, officer: CEO | F-InKind | 310 | $1.34 |
| Mar 13, 2026 | Albert Benjamin · director, officer: CEO | F-InKind | 70,455 | $1.85 |
| Mar 5, 2026 | Larson-Green Julie · director | A-Award | 8,361 | $0.00 |
| Mar 5, 2026 | Albert Benjamin · director, officer: CEO | F-InKind | 4,966 | $1.66 |
| Mar 5, 2026 | Llewelyn Linda · officer: Chief People Officer | F-InKind | 13,836 | $1.66 |
| Mar 5, 2026 | Alger Jason · officer: Chief Financial Officer | F-InKind | 26,970 | $1.66 |
| Mar 5, 2026 | Landry Benjamin · officer: General Counsel | F-InKind | 20,838 | $1.66 |
| Feb 27, 2026 | Llewelyn Linda · officer: Chief People Officer | A-Award | 13,195 | $0.00 |
| Feb 27, 2026 | Alger Jason · officer: Chief Financial Officer | A-Award | 22,222 | $0.00 |
| Feb 27, 2026 | Llewelyn Linda · officer: Chief People Officer | A-Award | 191,500 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 64Increased 69Reduced 78Sold out 43
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FIRST LIGHT ASSET MANAGEMENT, LLC | Reduced | 12,878,700 | May 15, 2026 |
| First Light Asset Management, LLC | Reduced | 12,810,861 | Aug 14, 2026 |
| CDC Financial, Inc. | Increased | 7,092,698 | Aug 14, 2026 |
| CDC Financial, Inc. | Increased | 6,307,054 | May 15, 2026 |
| WHETSTONE CAPITAL ADVISORS, LLC | Increased | 5,783,141 | May 15, 2026 |
| BLACKROCK, INC. | Reduced | 5,138,022 | May 13, 2026 |
| Palogic Value Management, L.P. | Increased | 4,922,442 | Sep 9, 2026 |
| Impax Asset Management Group plc | Increased | 4,000,000 | Aug 11, 2026 |
| Nepsis Inc. | Increased | 2,976,187 | Jul 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 2,971,598 | Aug 13, 2026 |
| PALOGIC VALUE MANAGEMENT, L.P. | Increased | 2,896,600 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,885,653 | May 15, 2026 |
| IMPAX ASSET MANAGEMENT GROUP PLC | Unchanged | 2,750,000 | May 12, 2026 |
| Caption Management, LLC | Increased | 2,473,650 | Aug 14, 2026 |
| CAPTION MANAGEMENT, LLC | New Position | 2,471,886 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 5, 2026